A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia.
about
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A phase 1 trial of vadastuxima ...... sitive acute myeloid leukemia.
@en
A phase 1 trial of vadastuxima ...... sitive acute myeloid leukemia.
@nl
type
label
A phase 1 trial of vadastuxima ...... sitive acute myeloid leukemia.
@en
A phase 1 trial of vadastuxima ...... sitive acute myeloid leukemia.
@nl
prefLabel
A phase 1 trial of vadastuxima ...... sitive acute myeloid leukemia.
@en
A phase 1 trial of vadastuxima ...... sitive acute myeloid leukemia.
@nl
P2093
P2860
P50
P1433
P1476
A phase 1 trial of vadastuxima ...... sitive acute myeloid leukemia.
@en
P2093
Amir T Fathi
Anand P Jillella
Anjali S Advani
Anthony S Stein
Baiteng Zhao
Charles Biddle-Snead
Dale Bixby
Daniel J DeAngelo
Eytan M Stein
Harry P Erba
P2860
P304
P356
10.1182/BLOOD-2017-06-789800
P407
P577
2017-12-01T00:00:00Z